BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Deals

  SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting

  SomaLogic, Inc., a leader in proteomics technology, announced that, based on the preliminary vote count provided by its proxy solicitors following the Company’s Special Meeting of Stockholders held earlier today, SomaLogic stockholders voted to approve the transaction with Standard BioTools Inc. .

  January 4, 2024

   · 

  7 min read
• Genetown

  Voyager Therapeutics Announces Pricing of Public Offering - Jan 05, 2024

  Voyager Therapeutics, Inc. announced the pricing of an underwritten public offering of 7,777,778 shares of its common stock at a public offering price of $9.00 per share.

  January 4, 2024

   · 

  5 min read
• Business

  Evolus Announces the Appointment of Nareg Sagherian to Vice President, Head of Global Investor Relations and Corporate Communications

  Evolus, Inc. announced that Nareg Sagherian has joined the Company as Vice President, Head of Global Investor Relations and Corporate Communications.

  January 4, 2024

   · 

  2 min read
• Pharm Country

  Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Jan 04, 2024

  Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced the grant of inducement awards to one new employee.

  January 4, 2024

   · 

  3 min read